Page last updated: 2024-11-05

tosufloxacin and Giardia duodenalis Infection

tosufloxacin has been researched along with Giardia duodenalis Infection in 1 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakaya, Y1
Shiota, S1
Sakamoto, K1
Iwase, A1
Aoki, S1
Matsuoka, R1
Tei, Y1
Okada, Y1
Miyake, Y1

Other Studies

1 other study available for tosufloxacin and Giardia duodenalis Infection

ArticleYear
Double infection with Giardia lamblia and Salmonella paratyphi A associated with acute renal failure.
    Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:5

    Topics: Acute Kidney Injury; Adult; Animals; Anti-Infective Agents; Antiprotozoal Agents; Antitrichomonal Ag

1998